| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |